Laura E. Niklason

CIK: 0001878075

Transaction Breakdown

Open Market Buys (P)2 (13.3%)

High conviction signal

Open Market Sales (S)8 (53.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

HUMA

Humacyte, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (15 total)

HUMA
Humacyte, Inc.
Jun 11, 2026
Award(A)
Stock Options (right to buy)
Indirect
80K shares-
HUMA
Humacyte, Inc.
Nov 16, 2025
Award(A)
Stock Options (right to buy)
Direct
311.1K shares-
HUMA
Humacyte, Inc.
Aug 20, 2025
Sale(S)
Indirect
591.7K shares at avg. $1.58$935K
HUMA
Humacyte, Inc.
Aug 19, 2025
Sale(S)
Indirect
1.1M shares at avg. $1.63$1.8M
HUMA
Humacyte, Inc.
Aug 18, 2025
Sale(S)
Indirect
549.4K shares at avg. $1.83$1.0M
HUMA
Humacyte, Inc.
Jun 12, 2025
Award(A)
Stock Options (right to buy)
Indirect
0 shares-
HUMA
Humacyte, Inc.
Jan 21, 2025
Award(A)
Stock Options (right to buy)
Direct
1.1M shares-
HUMA
Humacyte, Inc.
Dec 19, 2024
Award(A)
Stock Options (right to buy)
Direct
525 shares-
HUMA
Humacyte, Inc.
Nov 20, 2024
Sale(S)
Indirect
261.4K shares at avg. $4.40$1.2M
HUMA
Humacyte, Inc.
Nov 19, 2024
Purchase(P)
Direct
1.8K shares at avg. $4.44$8K
HUMA
Humacyte, Inc.
Nov 19, 2024
Sale(S)
Indirect
427.5K shares at avg. $4.34$1.9M
HUMA
Humacyte, Inc.
Nov 18, 2024
Sale(S)
Indirect
811.2K shares at avg. $4.44$3.6M
HUMA
Humacyte, Inc.
Sep 10, 2024
Sale(S)
Indirect
288.7K shares at avg. $5.23$1.5M
HUMA
Humacyte, Inc.
Sep 9, 2024
Sale(S)
Indirect
157.7K shares at avg. $5.42$855K
HUMA
Humacyte, Inc.
Aug 29, 2024
Purchase(P)
Direct
1.2K shares at avg. $6.54$8K

		Type	Shares	Price		Ownership
Jun 11, 2026	HUMA Humacyte, Inc.	Award(A) Stock Options (right to buy)	80,000	-	-	Indirect
Nov 16, 2025	HUMA Humacyte, Inc.	Award(A) Stock Options (right to buy)	311,100	-	-	Direct
Aug 20, 2025	HUMA Humacyte, Inc.	Sale(S)	591,685	$1.58	$934,862	Indirect
Aug 19, 2025	HUMA Humacyte, Inc.	Sale(S)	1,100,000	$1.63	$1,793,000	Indirect
Aug 18, 2025	HUMA Humacyte, Inc.	Sale(S)	549,360	$1.83	$1,005,329	Indirect
Jun 12, 2025	HUMA Humacyte, Inc.	Award(A) Stock Options (right to buy)	0	-	-	Indirect
Jan 21, 2025	HUMA Humacyte, Inc.	Award(A) Stock Options (right to buy)	1,130,311	-	-	Direct
Dec 19, 2024	HUMA Humacyte, Inc.	Award(A) Stock Options (right to buy)	525	-	-	Direct
Nov 20, 2024	HUMA Humacyte, Inc.	Sale(S)	261,369	$4.40	$1,150,024	Indirect
Nov 19, 2024	HUMA Humacyte, Inc.	Purchase(P)	1,797	$4.44	$7,979	Direct
Nov 19, 2024	HUMA Humacyte, Inc.	Sale(S)	427,459	$4.34	$1,855,172	Indirect
Nov 18, 2024	HUMA Humacyte, Inc.	Sale(S)	811,172	$4.44	$3,601,604	Indirect
Sep 10, 2024	HUMA Humacyte, Inc.	Sale(S)	288,674	$5.23	$1,509,765	Indirect
Sep 9, 2024	HUMA Humacyte, Inc.	Sale(S)	157,704	$5.42	$854,756	Indirect
Aug 29, 2024	HUMA Humacyte, Inc.	Purchase(P)	1,222	$6.54	$7,998	Direct

1-15 of 15 transactions

About Niklason Laura E

Niklason Laura E (SEC CIK 0001878075) files insider reports with the SEC as President, CEO and Director of Humacyte, Inc. (HUMA).

Signal8 holds 10 ownership filings by Niklason Laura E, all Form 4s, filed between Sep 3, 2024 and Jun 12, 2026. Those filings report 15 transactions, from Aug 29, 2024 to Jun 11, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Niklason Laura E's filings is in DURHAM, NC.

Recent filings by Niklason Laura E

Jun 11, 2026: Grant or award of HUMA derivative securities (Form 4, code A).
Nov 16, 2025: Grant or award of HUMA derivative securities (Form 4, code A).
Aug 20, 2025: Open-market sale of HUMA shares (Form 4, code S).
Aug 19, 2025: Open-market sale of HUMA shares (Form 4, code S).
Aug 18, 2025: Open-market sale of HUMA shares (Form 4, code S).

Other insiders filing for Humacyte, Inc. (HUMA)

COWARD D SCOTT, Director
Kuznik Paul Brian, Director
Jones Keith Anthony, Director
Windham-Bannister Susan Richards, Director
Constantino Michael T., Director
Wallace Max N., Director

How to read Form 4 transaction codes